J&J, Bayer Hit With $28M Verdict In 1st Xarelto Loss

Law360, Philadelphia (December 5, 2017, 12:31 PM EST) -- A Philadelphia jury delivered a first-of-its-kind verdict on Tuesday as it awarded almost $28 million in damages against a pair of Johnson & Johnson and Bayer AG units after finding the companies had provided inadequate warnings about the risks of bleeding associated with the blood thinner Xarelto.

Tuesday's trial loss for units of Bayer and Johnson & Johnson comes after they won three previous bellwether cases over Xarelto's risks. (Getty) The verdict, which credited claims from an Indiana woman who said she suffered a serious gastrointestinal bleed...
To view the full article, register now.